4C084 その他の医薬技術 Patent Trends
The Theme Code "その他の医薬技術" had 1,475 patent application filings in the publication-lag-adjusted comparison period (2024-01-01 to 2024-10-31). This is a significantly decreased of -1,639 filings (-52.6%) over 3,114 they had in the same period of the previous year (2023-01-01 to 2023-10-31).
The highest number of filings in 2021 with 5,248 cases, and their lowest number in 2024 with 1,522 cases (years covered: 2021, 2022, 2023, 2024).
The mean of the number of filings over the last 4 years (2021 to 2024, 15,004 cases in total) is 3,751, and the median is 4,117. The coefficient of variation (standard deviation/mean) is 0.4, and filings have been large fluctuations.
| Index | Value |
|---|---|
| Average | 3,751 patents |
| Std Dev | 1,387 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 158 cases | -89.6% |
| 2024 year | 1,522 cases | -59.8% |
| 2023 year | 3,788 cases | -14.80% |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for その他の医薬技術[4C084] for the period of the last 6 years (2020 to 2025). You can compare the information in this report with the trends in your competitors’ patent filings and technologies.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of その他の医薬技術, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, and their top coapplicants (joint research partners, alliance partners). It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
その他の医薬技術, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of その他の医薬技術 over the last 6 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
その他の医薬技術 JP patent filing trend (unit: cases)
| Year | Cases |
|---|---|
| 2021 | 5,248 |
| 2022 | 4,446 |
| 2023 | 3,788 |
| 2024 | 1,522 |
| 2025 | 158 |
Patent Landscape
Patent landscaping is a visualization of the distribution of patent filings (application focus areas) for each technical keyword. Mountains and islands indicated by heatmap contours represent clusters of patent applications filed, and red areas on the heatmap indicate many patent filings relating to the keyword.
The patent landscape for その他の医薬技術 gives an intuitive understanding of what patent filings they have made and what technical position is to be established. By selecting filing year checkboxes and filtering, you can track their past filing trends (what technical area they have focused on).
By selecting applicant/patent holder checkboxes and filtering, you can visually grasp the technical areas of the filings for each applicant and the partnerships or alliances formed. Please use it as a guide for patent analysis and IP landscaping.
Keywords (importance)
Top keywords frequently used in patent filings for その他の医薬技術 are shown below.
Top keywords for その他の医薬技術
| Keyword | Score |
|---|---|
| 組成 | 100.0 |
| 治療 | 63.52 |
| 細胞 | 47.96 |
| 疾患 | 43.93 |
| 活性 | 38.4 |
| 投与 | 33.1 |
| 予防 | 32.92 |
| 医薬 | 29.13 |
| 阻害 | 24.57 |
| 塩 | 23.92 |
| 結合 | 23.54 |
| 修正 | 21.84 |
| 発現 | 19.79 |
| 癌 | 19.18 |
| 炎症 | 17.8 |
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 15,162 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
その他の医薬技術[4C084]
Recent publications
| Publication No. | Title | Bibliographic info | Theme |
|---|---|---|---|
| 1. JPP7933376 | ２０１９－ｎＣｏＶ（ＳＡＲＳ－ＣｏＶ－２）ワクチン | ・Applicant ヴァックスバイオエルティーディー ・Filing date 2021-02-17 ・Publication date 2026-10-13 | 4B064, 4B065, 4C084, 4C085, 4C086, +2 more |
| 2. JPP7933683 | ＲＮＡ誘導型ヌクレアーゼとその活性な断片およびバリアント、ならびに利用の方法 | ・Applicant ライフエディットセラピューティクスインコーポレイティド ・Filing date 2021-04-23 ・Publication date 2026-10-13 | 4B050, 4B065, 4C084, 4C086, 4C087 |
| 3. JPP7933761 | プログラム細胞死－１タンパク質に対するモノクローナル抗体および医薬におけるその使用 | ・Applicant ビオンテック・ソシエタス・エウロパエア ・Filing date 2021-11-11 ・Publication date 2026-10-13 | 4B065, 4C076, 4C084, 4C085, 4C087, +1 more |
| 4. JPP7933374 | 免疫原性ＥＧＦＲペプチド組成物及び癌の治療におけるそれらの使用 | ・Applicant ボードオブレジェンツザユニバーシティオブテキサスシステム ・Filing date 2020-09-25 ・Publication date 2026-10-13 | 4B065, 4C076, 4C084, 4C085, 4C086, +2 more |
| 5. JPP7933732 | 保存製剤 | ・Applicant イーライリリーアンドカンパニー ・Filing date 2020-03-11 ・Publication date 2026-10-13 | 4C076, 4C084, 4H045 |
| 6. JPP7933763 | 異種間移植のための成長ホルモン受容体ノックアウトを有する多重トランスジェニックブタ | ・Applicant レビビコアインコーポレイテッド ・Filing date 2021-11-19 ・Publication date 2026-10-13 | 4B065, 4C081, 4C084, 4C087 |
| 7. JPP7933765 | ミトコンドリアベースのコレステロールの流動および異化の向上 | ・Applicant リペア・バイオテクノロジーズ・インコーポレイテッド ・Filing date 2021-12-08 ・Publication date 2026-10-13 | 4B063, 4B065, 4C084, 4C087, 4H045 |
| 8. JPP7934035 | ｃＧＡＳ阻害剤としての環式ベンゾイミダゾール誘導体 | ・Applicant ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング ・Filing date 2023-11-03 ・Publication date 2026-10-13 | 4C084, 4C085, 4C086 |
| 9. JPP7934059 | 筋特異的発現カセット | ・Applicant プレシジョンバイオサイエンシズインク ・Filing date 2024-04-12 ・Publication date 2026-10-13 | 4B065, 4C084, 4C087 |
| 10. JPP7933375 | タンパク質合成を増強するためのＣＲＩＳＰＲ－Ｃａｓ１３による標的ＲＮＡ翻訳 | ・Applicant ユニバーシティオブロチェスター ・Filing date 2021-02-05 ・Publication date 2026-10-13 | 4B064, 4C084, 4H045 |
| 11. JPP7933412 | ＩＬ１３Ｒα２陽性ヒト腫瘍およびイヌ腫瘍を処置するための合成ＣＡＲ | ・Applicant ザトラスティーズオブザユニバーシティオブペンシルバニア ・Filing date 2020-08-27 ・Publication date 2026-10-13 | 4B065, 4C084, 4C087, 4H045 |
| 12. JPP7933427 | クローディン１８．２に特異的に結合する単クローン抗体及びその用途 | ・Applicant トリオール・インコーポレイテッド ・Filing date 2023-12-22 ・Publication date 2026-10-13 | 4B064, 4B065, 4C076, 4C084, 4C085, +2 more |
| 13. JPP7933766 | 腎不全患者におけるＧＬＰ－２アナログの使用 | ・Applicant ジーランドファーマアクティーゼルスカブ ・Filing date 2021-12-15 ・Publication date 2026-10-13 | 4C084, 4H045 |
| 14. JPP7933921 | ＡｐｏＥ抗体、融合タンパク質、およびその使用 | ・Applicant ザジェネラルホスピタルコーポレイション, ザスケペンスアイリサーチインスティテュートインコーポレイテッド, バナーヘルス ・Filing date 2020-05-28 ・Publication date 2026-10-13 | 4B064, 4B065, 4C084, 4C085, 4H045 |
| 15. JPA2026-165009 | 外用剤 | ・Applicant 国立大学法人佐賀大学, 国立大学法人富山大学 ・Filing date 2025-01-06 ・Publication date 2026-10-13 | 4C084, 4C086 |
Same industry / competition company information (JP)
{'ja': '技術テーマ「その他の医薬技術」における上位出願人の特許情報を以下に示します。各企業の特許件数を比較することで、過去および現在の各社の技術テーマにおける研究開発状況や、技術テーマにおける各社の位置付けを確認できます。なお、特許は出願から公開までに一年半のタイムラグがあるため、一年半より直近の状況については分析できない点に注意する必要があります。', 'en': "The patent information of the higher applicant in the technical theme その他の医薬技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme. Patents have a time lag of about 18 months from filing to publication."}
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 57 cases, followed by イーライリリーアンドカンパニー with 46 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 57 cases |
| イーライリリーアンドカンパニー | 46 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 38 cases |
| ノバルティスアーゲー | 37 cases |
| ギリアードサイエンシーズインコーポレイテッド | 26 cases |
| ジェネンテックインコーポレイテッド | 22 cases |
Trends in filing of joint patent applications for the target period (2020 to 2025).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last for the target period (2020 to 2025) with 241 cases, followed by ノバルティスアーゲー with 203 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 241 cases |
| ノバルティスアーゲー | 203 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 160 cases |
| ジェネンテックインコーポレイテッド | 146 cases |
| ギリアードサイエンシーズインコーポレイテッド | 123 cases |
| イーライリリーアンドカンパニー | 122 cases |
Same industry / competition company JP patent filing ranking
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業の長期推移をどう読むか
同業や競合企業の長期的な特許出願件数の推移から、長期トレンドと出願件数の山や谷を確認することができます。
解説の続きを読む
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 6 companies in the same industry over the past 6 years.
Competitor filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 241 |
| ノバルティスアーゲー | 203 |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 160 |
| ジェネンテックインコーポレイテッド | 146 |
| ギリアードサイエンシーズインコーポレイテッド | 123 |
| イーライリリーアンドカンパニー | 122 |
Top company information (JP)
{'ja': '技術テーマ「その他の医薬技術」における上位出願人の特許情報を以下に示します。各企業の特許件数を比較することで、過去および現在の各社の技術テーマにおける研究開発状況や、技術テーマにおける各社の位置付けを確認できます。なお、特許は出願から公開までに一年半のタイムラグがあるため、一年半より直近の状況については分析できない点に注意する必要があります。', 'en': "The patent information of the higher applicant in the technical theme その他の医薬技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme. Patents have a time lag of about 18 months from filing to publication."}
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業との比較のポイント
同業や競合企業が特許に注力している分野を知ることで、自社の戦略や製品開発の方向性を把握することができます。
解説の続きを読む
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 57 cases, followed by イーライリリーアンドカンパニー with 46 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 57 cases |
| イーライリリーアンドカンパニー | 46 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 38 cases |
Trends in filing of joint patent applications for the target period (2020 to 2025).
among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last for the target period (2020 to 2025) with 241 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 160 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 241 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 160 cases |
| イーライリリーアンドカンパニー | 122 cases |
Top company JP patent filing ranking
Below is a ranking of the number of JP patent applications by その他の医薬技術’s top 3 coapplicants over the last 6 years.
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業の長期推移をどう読むか
同業や競合企業の長期的な特許出願件数の推移から、長期トレンドと出願件数の山や谷を確認することができます。
解説の続きを読む
Top co-applicant filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 241 |
| ノバルティスアーゲー | 203 |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 160 |
Top company, Change in the Number of JP Patents
Below is a patent map showing the changes in the numbers of JP patent filings by その他の医薬技術’s top 3 coapplicants over the last 6 years.
Top co-applicant filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 241 |
| ノバルティスアーゲー | 203 |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 160 |
Top company details
Trends in filing of joint patent applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド
その他の医薬技術 filed 241 joint applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 241 cases in total) is 48.2, and the median is 49.0. The coefficient of variation (standard deviation/mean) is 0.4, and filings have been large fluctuations.
Because some years show zero filings in the collected data, strong trend claims are avoided; see the yearly table. The highest number of filings in 2020 with 81 cases, and their lowest number in 2024 with 15 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 48.2 patents |
| Std Dev | 21.2 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 0 cases | -100% |
| 2024 year | 15 cases | -64.3% |
| 2023 year | 42 cases | -22.22% |
Trends in filing of joint patent applications with イーライリリーアンドカンパニー
その他の医薬技術 filed 122 joint applications with イーライリリーアンドカンパニー for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 117 cases in total) is 23.4, and the median is 24.0. The coefficient of variation (standard deviation/mean) is 0.26, and filings have been large fluctuations.
The highest number of filings in 2022 with 32 cases, and their lowest number in 2024 with 14 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 23.4 patents |
| Std Dev | 6.1 |
| COV | 0.26 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 5 cases | -64.3% |
| 2024 year | 14 cases | -48.1% |
| 2023 year | 27 cases | -15.62% |
Trends in filing of joint patent applications with ザリージェンツオブザユニバーシティオブカリフォルニア
その他の医薬技術 filed 160 joint applications with ザリージェンツオブザユニバーシティオブカリフォルニア for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 160 cases in total) is 32.0, and the median is 33.0. The coefficient of variation (standard deviation/mean) is 0.5, and filings have been large fluctuations.
Because some years show zero filings in the collected data, strong trend claims are avoided; see the yearly table. The highest number of filings in 2020 with 55 cases, and their lowest number in 2024 with 5 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 32.0 patents |
| Std Dev | 16.1 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 0 cases | -100% |
| 2024 year | 5 cases | -84.8% |
| 2023 year | 33 cases | +13.79% |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業との比較のポイント
同業や競合企業が特許に注力している分野を知ることで、自社の戦略や製品開発の方向性を把握することができます。
解説の続きを読む